SCHEMBL21547553

SCHEMBL21547553

CCC#Cc1ccnnc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 6/20 0.38
CHRNA4 P43681 6/20 0.38
CYP2A6 P11509 5/20 0.38
CYP2B6 P20813 4/20 0.38
CYP2C19 P33261 4/20 0.38
CYP2C9 P11712 3/20 0.38
CYP2E1 P05181 3/20 0.36
CYP3A4 P08684 2/20 0.36
CYP2D6 P10635 2/20 0.36
CYP1A2 P05177 2/20 0.35
CYP2C8 P10632 1/20 0.35
GRM5 P41594 1/20 0.35
LOXL2 Q9Y4K0 1/20 0.34
HAO1 Q9UJM8 2/20 0.33
NPSR1 Q6W5P4 1/20 0.32
GABRP O00591 1/20 0.32
GABRD O14764 1/20 0.32
GABRA1 P14867 1/20 0.32
GABRB1 P18505 1/20 0.32
GABRG2 P18507 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19968374 0.77 CHRNB2 (0.37) CHRNB2CHRNA4CYP2A6CYP2B6CYP2C19
SCHEMBL13573664 0.76
SCHEMBL14985138 0.76 HDAC8 (0.42) CHRNB2CHRNA4CYP2A6CYP2B6CYP2C19
SCHEMBL17039130 0.73 LOXL2 (0.47) LOXL2
SCHEMBL7052162 0.73 CYP2A6 (0.68) CHRNB2CHRNA4CYP2A6CYP2B6CYP2C19
SCHEMBL13765866 0.72 GRM5 (0.35) GRM5LOXL2GABRA1GABRG2GABRB3
SCHEMBL8574111 0.71 CHRNB2 (0.37) CHRNB2CHRNA4CYP2A6CYP2B6CYP2C19
SCHEMBL17036555 0.71 HRH3 (0.38) CYP2D6GRM5LOXL2HAO1
SCHEMBL16077761 0.71 GRM5 (0.35) CYP2A6GRM5LOXL2HAO1
SCHEMBL17050214 0.67 GRM5 (0.48) CHRNB2CHRNA4CYP2A6CYP2B6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3110418-B1 ARYL, HETEROARYL, AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS ACHILLION PHARMACEUTICALS INC (US) 2019-11-06 EP disclosed